Autophagy and Metabolism

Potential Target for Cancer Therapy
Erscheinungsjahr 2022
ISBN: 978-0-323-99879-6
Verlag: William Andrew Publishing

Buch, Englisch, 362 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 450 g

Autophagy and Metabolism: Potential Target for Cancer Therapy presents updates on autophagy in cancer metabolism and how it can be used to develop new, more efficient treatments. Written by experts in the field, the book presents recent research and explains how to translate it to the clinical setting. Sections discuss tumor cell metabolism and autophagy as therapeutic targets, autophagy regulation in cancer, signaling pathways in metabolic dysregulation in solid tumors, metabolic stress and cell death pathways, and the role of the tumor microenvironment. In addition, topics cover combined targeting autophagy, metabolism for cancer therapy, and the autophagy effect on immune cell metabolism.

This will be a valuable resource for researchers, oncologists, graduate students, and members of the biomedical field who are interested in learning more about the interaction between autophagy and cancer metabolism.

Autoren/Hrsg.

Kumar, Dhruv

Asthana, Shailendra

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

1. Role of metabolic dysregulation in cancer progression2. Role of Autophagy in Cancer Metabolism: Molecular Mechanisms3. Tumor Cell Metabolism and Autophagy as Therapeutic Targets4. Autophagy Regulation in Cancer: Current Knowledge on Action and Therapy5. Signaling pathways in metabolic dysregulation in solid tumors6. Metabolic Stress in Autophagy and Cell Death Pathways in Cancer7. Role of Tumor Microenvironment in Autophagy and Metabolism in Cancer8. Autophagy and Metabolic Regulation in cancer stem cells: molecular mechanisms and therapeutic applications9. Mitophagy in cancer and cancer stem cells: a role in metabolic reprogramming10. Combined targeting autophagy and metabolism for cancer therapy11. Designing metabolic target specific inhibitors for cancer therapy12. Effect of autophagy on immune cell metabolism and the effect of metabolites on autophagy activity

Über Autor(innen)

Asthana, Shailendra
Shailendra Asthana is a Senior Scientist at Translational Health Science and Technology Institute (THSTI), India. He has more than 20 years of research experience in drug discovery, autophagy, and bioinformatics. The goal of his research is to improve atomic level understanding of protein-ligand, protein-nucleic acid, protein-peptide and protein-protein interactions using computational models and tools. Using molecular modeling, molecular docking and physics-based methods such as molecular dynamics simulations, Dr. Asthana and his research group focus on how small molecules interact with proteins and thereby modulate their function.

Kumar, Dhruv
Dr. Dhruv Kumar is a Senior Associate Professor at School of Health Sciences and Technology, UPES University, Dehradun, India and his current research is focused on autophagy, cancer cell metabolism, tumour microenvironment, exosomes, mutational heterogeneity, cancer prevention, drug designing, NGS and COVID-19. After completion of B.Sc. in Chemistry from Banaras Hindu University (BHU) and M.Sc. in Bioinformatics from University of Allahabad, India, he has completed his Ph.D. in Cellular, Molecular and Industrial Biology from the University of Bologna (UNIBO), under highly prestigious fellowship, Indo-Italian Government fellowship. After his Ph.D., he obtained Postdoctoral training at the University of Kansas Medical Center, USA. During his Postdoctoral training, he worked towards understanding the molecular mechanism(s) of autophagy regulation and apoptosis in cancer stem cells (prostate, pancreatic and breast), focusing on the metabolic cross-talk between the tumour microenvironment (cancer associated fibroblast (CAF)) and head and neck squamous cell carcinoma (HNSCC) via HGF/c-MET and bFGF/FGFR signalling pathways. He has also worked on structure based drug designing for several cancers, COVID-19, mutational heterogeneity in cancer. Currently, his lab is focusing on metabolic heterogeneity in solid tumours and structure based drug designing for cancer and COVID-19. He has published more than 100 research articles, reviews and book chapters in reputed journals.